What is the recommendation for adults with immunocompromising conditions regarding the use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine?
The Advisory Committee on Immunization Practices (ACIP) recommends the use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions. This recommendation is published in the MMWR Morb Mortal Wkly Rep. 2012;61:816 9. The ACIP also published a more comprehensive recommendation for the prevention of pneumococcal disease in 1997, which is published in the MMWR Recomm Rep. 1997;46:1 24.